American Research & Management Co. Novo Nordisk A S Transaction History

American Research & Management Co.

$362 Million
Q3 2022

A detailed history of American Research & Management Co. transactions in Novo Nordisk A S stock. As of the latest transaction made, American Research & Management Co. holds 24,587 shares of NVO stock, worth $3.41 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

24,587

Previous 24,587 -0.0%

Holding current value

$3.41 Million

Previous $2.74 Million 10.58%

% of portfolio

0.68%

Previous 0.7%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$103.24 - $121.81 $8,981 - $10,597	87 Added 0.36%	24,587 $2.74 Million
Q1 2022 Apr 21, 2022	SELL	$93.1 - $112.54 $17,502 - $21,157	-188 Reduced 0.76%	24,500 $2.72 Million
Q4 2021 Jan 28, 2022	SELL	$95.88 - $117.08 $9,588 - $11,708	-100 Reduced 0.4%	24,688 $2.77 Million
Q3 2021 Oct 28, 2021	SELL	$84.42 - $106.62 $31,657 - $39,982	-375 Reduced 1.49%	24,788 $2.38 Million
Q2 2021 Jul 16, 2021	SELL	$67.66 - $84.76 $2,029 - $2,542	-30 Reduced 0.12%	25,163 $2.11 Million

Q1 2021 Apr 06, 2021	SELL	$67.06 - $75.82 $18,441 - $20,850	-275 Reduced 1.08%	25,193 $1.7 Million
Q4 2020 Jan 28, 2021	SELL	$63.89 - $73.8 $14,375 - $16,605	-225 Reduced 0.88%	25,468 $1.78 Million
Q3 2020 Oct 29, 2020	SELL	$63.69 - $70.22 $12,738 - $14,044	-200 Reduced 0.77%	25,693 $1.78 Million
Q2 2020 Jul 28, 2020	SELL	$58.54 - $67.94 $7,727 - $8,968	-132 Reduced 0.51%	25,893 $1.7 Million
Q1 2020 Apr 28, 2020	SELL	$49.46 - $64.78 $96,447 - $126,321	-1,950 Reduced 6.97%	26,025 $1.57 Million
Q4 2019 Jan 17, 2020	BUY	$49.86 - $58.26 $39,888 - $46,608	800 Added 2.94%	27,975 $1.62 Million
Q3 2019 Oct 31, 2019	SELL	$47.54 - $53.43 $16,639 - $18,700	-350 Reduced 1.27%	27,175 $1.41 Million
Q2 2019 Jul 18, 2019	BUY	$46.79 - $52.47 $21,055 - $23,611	450 Added 1.66%	27,525 $1.41 Million
Q4 2018 Feb 12, 2019	BUY	$41.54 - $47.25 $51,925 - $59,062	1,250 Added 4.84%	27,075 $1.25 Million
Q3 2018 Oct 04, 2018	SELL	$46.76 - $51.24 $19,873 - $21,777	-425 Reduced 1.62%	25,825 $1.22 Million
Q2 2018 Jul 25, 2018	BUY	$44.29 - $50.42 $178,267 - $202,940	4,025 Added 18.11%	26,250 $1.21 Million
Q4 2017 Feb 08, 2018	SELL	$47.53 - $53.73 $1,188 - $1,343	-25 Reduced 0.11%	22,225 $1.19 Million
Q3 2017 Oct 17, 2017	BUY	$41.15 - $49.22 $915,587 - $1.1 Million	22,250	22,250 $1.07 Million

Others Institutions Holding NVO

# of Institutions

1,859

Shares Held

310M

Call Options Held

5.29M

Put Options Held

4.93M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $313B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Research & Management Co., based on Form 13F filings with the SEC.

News

Stay updated on American Research & Management Co. with notifications on news.

Account

American Research & Management Co. Novo Nordisk A S Transaction History